Panbela to present at h.c. wainwright 25th annual global investment conference

Minneapolis, aug. 28, 2023 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, announced that management will be presenting virtually at the h.c. wainwright 25th annual global investment conference.
PBLA Ratings Summary
PBLA Quant Ranking